Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma

Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma

(2017) Andrew M Donson et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients

(2017) Hojabr Kakavand et al.   MODERN PATHOLOGY

Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer

(2017) Olivier Bylicki et al.   Targeted Oncology

Distinct patterns of primary and motile cilia in Rathke’s cleft cysts and craniopharyngioma subtypes

(2016) Shannon Coy et al.   MODERN PATHOLOGY

Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice

(2016) John Richard Apps et al.   Neurosurgical Focus

Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics

(2016) Leslie C. Robinson et al.   Neurosurgical Focus

A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications

(2016) Kelly Lamiman et al.   Neurosurgical Focus

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy

(2016) Ju Yeon Lee et al.   Nature Communications

Quality of Life and Clinical Features of Long-Term Survivors Surgically Treated for Pediatric Craniopharyngioma

(2016) Shigetoshi Yano et al.   World Neurosurgery

Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles

(2016) Annett Hölsken et al.   Acta Neuropathologica Communications

Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth

(2015) Sonja Kleffel et al.   CELL

ENDOCRINE TUMORS:BRAFV600E mutations in papillary craniopharyngioma

(2015) Priscilla K Brastianos et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

(2015) N. A. Rizvi et al.   SCIENCE

Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method

(2015) Jia-Ren Lin et al.   Nature Communications

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma

(2015) Ziming Du et al.   Oncotarget

Insights into the Infiltrative Behavior of Adamantinomatous Craniopharyngioma in a New Xenotransplant Mouse Model

(2014) Christina Stache et al.   BRAIN PATHOLOGY

Childhood Craniopharyngioma – Changes of Treatment Strategies in the Trials KRANIOPHARYNGEOM 2000/2007

(2014) A. Hoffmann et al.   KLINISCHE PADIATRIE

PD-1 blockade induces responses by inhibiting adaptive immune resistance

(2014) Paul C. Tumeh et al.   NATURE

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas

(2014) Priscilla K Brastianos et al.   NATURE GENETICS

Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma

(2013) Lindsey M. Hoffman et al.   ACTA NEUROPATHOLOGICA

Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011

(2013) M. Cohen et al.   NEURO-ONCOLOGY

Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?

(2013) Annett Hölsken et al.   Pituitary

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

(2013) E. A. Akbay et al.   Cancer Discovery

Treatment-related morbidity and the management of pediatric craniopharyngioma

(2012) Aaron J. Clark et al.   Journal of Neurosurgery-Pediatrics

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas

(2011) A. Holsken et al.   CLINICAL CANCER RESEARCH

CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes

(2010) B. H. Nelson   JOURNAL OF IMMUNOLOGY